These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6192408)

  • 21. Influence of i.v. haloperidol on ventricular repolarization and monophasic action potential duration in anesthetized dogs.
    Rasty S; Amin NB; Sabbah HN; Mishima T; Borzak S; Tisdale JE
    Chest; 2004 May; 125(5):1821-9. PubMed ID: 15136396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential sensitivity of sinus node, atrioventricular node, atrium, and ventricle to propranolol.
    Chang MS; Zipes DP
    Am Heart J; 1988 Aug; 116(2 Pt 1):371-8. PubMed ID: 3400563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
    Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of ejection fraction and segmental circumferential fiber shortening velocity in the anesthetized and conscious canine.
    Laks MM; Greenless L; Garner D
    Jpn Heart J; 1979 May; 20(3):359-65. PubMed ID: 459103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J; Basiez M; Massingham R
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A time-course study of the effects of pentobarbital, fentanyl, and morphine chloralose on myocardial mechanics.
    Lang RM; Marcus RH; Neumann A; Janzen D; Hansen D; Fujii AM; Borow KM
    J Appl Physiol (1985); 1992 Jul; 73(1):143-50. PubMed ID: 1506361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the beta-adrenergic blocking agents propranolol and timolol on canine cardiac refractory periods.
    Jaillon P; Weissenburger J; Heckle J; Cheymol G
    Eur J Pharmacol; 1979 Oct; 58(3):265-71. PubMed ID: 510358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between refractory periods and activation-recovery intervals from electrograms: effects of rate and adrenergic interventions.
    Millar CK; Kralios FA; Lux RL
    Circulation; 1985 Dec; 72(6):1372-9. PubMed ID: 4064279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human ventricular refractoriness. Effects of cycle length, pacing site and atropine.
    Guss SB; Kastor JA; Josephson ME; Schare DL
    Circulation; 1976 Mar; 53(3):450-5. PubMed ID: 1248076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death.
    Venkatesh N; Lynch JJ; Uprichard AC; Kitzen JM; Singh BN; Lucchesi BR
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):703-10. PubMed ID: 1723767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are QT measurements on body surface ECG indicative of ventricular refractory patterns?
    Voss F; Becker R; Bauer A; Kraft P; Senges-Becker JC; Katus HA; Schoels W
    Basic Res Cardiol; 2005 Jan; 100(1):22-7. PubMed ID: 15490201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Description of the strength-interval relation with external noninvasive pacing.
    Luck JC; Grubb BP; Markel ML
    Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 2):2031-7. PubMed ID: 1704588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular mechanical consequences of dihydropyridine calcium channel modulation in conscious and anesthetized chronically instrumented dogs.
    Pagel PS; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Jul; 81(1):190-208. PubMed ID: 7519000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
    Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variant forms of AV and VA conduction in the canine heart.
    Scherlag BJ; Munsif A; Nakagawa H; Hirao K; Lazzara R
    J Electrocardiol; 1993; 26 Suppl():227-37. PubMed ID: 8189130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [QT time and the ventricular refractory period in programmed electrical stimulation of the heart in patients with ventricular and supraventricular tachycardias--effect of sotalol].
    Wehr M
    Z Kardiol; 1986 Dec; 75(12):744-50. PubMed ID: 3825224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of ventricular arrhythmias by volatile anesthetics in a canine model of chronic myocardial infarction.
    Deutsch N; Hantler CB; Tait AR; Uprichard A; Schork MA; Knight PR
    Anesthesiology; 1990 Jun; 72(6):1012-21. PubMed ID: 2350016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.